Martin G. Pomper

2026 ERF Benedict Cassen Lectureship — PSMA: Origins and Outlook

Abstract placeholder. Drop in the official SNMMI session abstract once published.

Day and time to be confirmed against the SNMMI program.

1. How are you handling dosimetry standardization across sites in your trials?
2. What's your honest read on the supply ramp for Lu-177 over the next 18 months?
3. What's the actual bottleneck right now, isotopes, hot cells, or trained technologists?

Generated by a mock model. Wired to Anthropic when the API key is in place.

What we're seeing

• Reuters Health · 2026-09-20
  Martin G Pomper presents updated trial data at ASCO Annual Meeting
  The announcement comes amid tightening Mo-99 and Lu-177 supply.
• Endpoints News · 2026-02-27
  Martin G Pomper co-authors review on PSMA in Journal of Nuclear Medicine
  The work builds on more than a decade of radiochemistry collaboration.
• FierceBiotech · 2026-03-22
  Martin G Pomper cited in NEJM perspective on theranostic standardization
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• BioPharma Reporter · 2026-12-01
  Martin G Pomper joins editorial board of European Journal of Nuclear Medicine
  The work builds on more than a decade of radiochemistry collaboration.
• Imaging Wire · 2026-09-08
  Martin G Pomper comments on FDA guidance for radiopharmaceutical trials
  The announcement comes amid tightening Mo-99 and Lu-177 supply.

Mocked while we wire the Exa integration. Headlines are illustrative.